China plans to spend about $940b on cleaner energy infrastructure in 2026, and that kind of multi decade shift can create supportive conditions for companies that can grow earnings steadily while keeping their finances in good shape. Investors looking for businesses that combine solid balance sheets with strong earnings potential over the next few years may find this especially timely. This article highlights three such high growth candidates from our screener.
The three stocks highlighted here offer a compelling starting point if you want exposure to healthier high growth businesses that pair earnings potential with relatively sound finances. However, if you want the pick of this theme, these 511 best high growth potential stocks are the best of the best.
Micronics Japan (TSE:6871)
Micronics Japan develops semiconductor test equipment and probe cards linked directly to the Healthy high growth potential theme, plus body measuring and display inspection tools. The probe card business generates about ¥84.9b against ¥1.4b for TE. The stock’s market value is roughly ¥345.9b.
Micronics Japan appears in this screener as a focused way to gain exposure to semiconductor test demand, with probe cards and wafer probers tied directly to chip production. Forecast earnings growth of 24.88% a year and strong ROE sit on top of rising guidance. However, the outlook is significantly influenced by developments in the memory semiconductor cycle.
That cyclic swing makes it even more important to read the 2 key rewards and 2 important warning signs (1 is major!) before deciding how Micronics Japan fits into your growth watchlist.
Vaxcyte (PCVX)
Vaxcyte is a clinical stage vaccine developer focused on conjugate and protein based shots like VAX-24 and VAX-31 that target serious bacterial infections. This is a clear fit with the Healthy high growth potential theme, and the business currently carries a market value of about US$10.1b.
The bullish analyst Narrative on Simply Wall St argues that Vaxcyte fits this screen because its late stage pneumococcal programs give it a clear path to the kind of earnings acceleration and financial resilience investors look for in higher quality growth stories.
OPUS-1’s use of a tighter 0.667 OPA GMR margin and broad non inferiority against existing adult vaccines sets a higher comparative bar for any future higher valency entrants, which could support longer lasting pricing power and gross margins if Vaxcyte becomes the reference product for adult PCVs.
What happens to that potential depends heavily on how one still unresolved pressure around funding and future dilution shapes investor confidence in the next phase.
That funding overhang is exactly why it pays to read the full narrative for Vaxcyte, which lays out how Vaxcyte could turn clinical progress into accelerating earnings power.
Space Exploration Technologies (SPCX)
Space Exploration Technologies runs rockets, Starlink broadband, and a fast growing AI platform. It fits the Healthy high growth potential theme through its Connectivity segment, which generates about US$16.0b of the US$31.0b total revenue, alongside US$4.2b from Space and US$11.9b from Super Intelligence, with a roughly US$1,823.5b market value.
Space Exploration Technologies matters for this theme because Starlink and the wider business aim to turn rapid top line expansion into healthier earnings over time. According to Marek_Trnka, an investor in the Simply Wall St Community, that hinges on how its profit engines stack up inside the group.
"Starlink satellite internet is currently the main driver of revenue and is the only division reporting an operating profit."
What that means for future margins and cash generation will depend heavily on how one still unresolved funding pressure plays out.
That funding question makes it even more important to read the full narrative for Space Exploration Technologies, which explains how Space Exploration Technologies could turn today’s profit engine into broader accelerating cash generation.
Seeking Alternatives Before The Crowd?
Fresh ideas move first. Breakout trends build momentum while the best entry points quietly drop away under the radar for now. Do not delay. Get in early.
- Target durable income streams by scanning dividend payers in the 35 dividend fortresses before yields get compressed by investors who are chasing the same cash flow.
- Spot future infrastructure candidates by reviewing the 42 power grid technology and infrastructure stocks while these grid technology companies are still flying under most watchlists.
- Track the automation trend by shortlisting companies from the 91 robotics and automation stocks before more capital focuses on the same opportunities.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com